GGrantIndex
Sort

51,593 grants matching hepatitis

New Congenital Disorders of Glycosylation: Therapy and Models

$412,576
Hudson H Freeze · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · DK

New Congenital Disorders of Glycosylation: Therapy and Models

$412,576
Hudson H Freeze · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · DK

Immune complexes: origins and effects in HCV infection

$412,571
Lynn B Dustin · Rockefeller University · R01 · FY2006 · AI

Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment

$412,552
Bernard Mark Evers · University Of Kentucky · R01 · FY2019 · CA

Functional Analysis of MGAT Enzymes

$412,519
Robert V Farese · J. David Gladstone Institutes · R01 · FY2009 · DK

Role of Inflammation in Tax-mediated Tumorigenesis

$412,519
Lee Ratner · Ohio State University · P01 · FY2009 · CA

Colorado Center of Childhood Liver Disease ResearchNetwork

$412,508
Ronald J Sokol · University Of Colorado Denver · U01 · FY2025 · DK

Towards a Vaccine for the Common Cold

$412,500
Thomas J Smith · Donald Danforth Plant Science Center · R01 · FY2009 · AI

Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicity

$412,500
Cheng Ji · University Of Southern California · R01 · FY2017 · DA

Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicity

$412,500
Cheng Ji · University Of Southern California · R01 · FY2021 · DA

Hepatitis B virus e antigen in viral persistence

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2017 · AI

Hepatitis B virus e antigen in viral persistence

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2020 · AI

Towards a Vaccine for the Common Cold

$412,500
Thomas J Smith · Donald Danforth Plant Science Center · R01 · FY2010 · AI

HCV VARIANTS AND IMMUNE RESPONSE IN INJECTION DRUG USERS

$412,500
Northern California Institute Res &Educ · R01 · FY2004 · DA

Autophagy and the Replication of Hepatitis B Virus

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2022 · AI

Restoration of immunity and function with DAA treatment in HCV infection

$412,500
Hugo R Rosen · University Of Southern California · R01 · FY2020 · AI

Restoration of immunity and function with DAA treatment in HCV infection

$412,500
Hugo R Rosen · University Of Southern California · R01 · FY2019 · AI

Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicity

$412,500
Cheng Ji · University Of Southern California · R01 · FY2020 · DA

Autophagy and the Replication of Hepatitis B Virus

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2020 · AI

Autophagy and the Replication of Hepatitis B Virus

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2021 · AI

Autophagy and the Replication of Hepatitis B Virus

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2024 · AI

Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicity

$412,500
Cheng Ji · University Of Southern California · R01 · FY2019 · DA

Hepatitis B virus e antigen in viral persistence

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2021 · AI

Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicity

$412,500
Cheng Ji · University Of Southern California · R01 · FY2018 · DA

Autophagy and the Replication of Hepatitis B Virus

$412,500
J.-H. James Ou · University Of Southern California · R01 · FY2023 · AI